Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Thermo Fisher Scientific continues growth trajectory

By Brian Buntz | October 23, 2020

Thermo Fisher Scientific (NYSE:TMO), the maker of scientific instruments, reagents and consumables, is having a banner year. The Waltham, Mass.-based company’s stock has hit an all-time high of $481.99. That amounts to a 48% increase since the beginning of the year.

Thermo Fisher raked in $2 billion in COVID-19 revenue from July to September, driving a 36% bump in year-over-year revenue.

Pharma and biotech, the company’s largest segments, were up 20% in the third quarter.

The Waltham, Mass.-based company posted profits of $1.93 billion, or $4.84 per share, on sales of $8.52 billion for the three months ended Sept. 26, 2020, more than doubling the bottom line on sales growth of 35.9% compared with Q3 2019.

“Our performance was a combination of our significant pandemic response and the return to growth in our base business,” Thermo Fisher CEO Marc N. Casper said during the company’s third-quarter earnings call.

Thermo Fisher announced that it took significant steps in the third quarter of the year to expand its pandemic response with increased automation of high-throughput PCR-based testing and increased logistical capacity for viral transport media in Europe. Additionally, the company debuted two COVID-19 antibody tests in the U.S. and Europe.

Tell Us What You Think! Cancel reply

Related Articles Read More >

dart board
How Target Value Delivery can help keep pharma construction projects on track 
Emergent Biosolutions
Emergent hid quality problems from FDA, House report concludes
Coding
How low code platforms can transform the COTS product development in pharma
Amgen
Why Wake County, North Carolina is gaining ground as a biotech hub

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards